Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hizentra® in Inflammatory Neuropathies - pHeNIx Study
Sponsor: CSL Behring
Summary
The pHeNIx study, a national multicentre prospective non-interventional study, should help to describe the conditions of use for Hizentra® and the methods for switching from the IV to SC route in everyday practice, together with the tolerability and efficacy of treatment, which is monitored using a patient application (PRO: Patient-Reported Outcomes).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2022-06-10
Completion Date
2027-12
Last Updated
2025-01-07
Healthy Volunteers
No
Interventions
Hizentra
Solution for injection for subcutaneous use
Locations (27)
CHU Amiens Picardie 1
Amiens, France
CHU Angers
Angers, France
Hôpital privé de La Casamance
Aubagne, France
CH Bayonne
Bayonne, France
Hôpital Pellegrin
Bordeaux, France
CHRU Brest
Brest, France
Hôpital Henri Mondor
Créteil, France
Hôpital Bicêtre
Le Kremlin-Bicêtre, France
CH Libourne
Libourne, France
Hôpital Roger Salengro, CHU Lille
Lille, France
Hôpital Dupuytren
Limoges, France
Hôpital Pierre Wertheimer,HCL
Lyon, France
Hôpital de la Timone
Marseille, France
CHU Montpellier
Montpellier, France
CHRU Nancy
Nancy, France
CHU Nantes
Nantes, France
Hôpital Pasteur
Nice, France
Hôpital Lariboisière
Paris, France
La Pitié-Salpêtrière
Paris, France
CHU Poitiers
Poitiers, France
Centre hospitalier privé Saint Grégoire
Rennes, France
Hôpital Charles Nicolle
Rouen, France
CHU Saint-Etienne
Saint-Etienne, France
CHU de Strasbourg
Strasbourg, France
CHU Toulouse
Toulouse, France
CHR Tours
Tours, France
CH de Valence
Valence, France